Related Experiment Videos
Safety of vaccines produced in continuous cell lines
1Biologicals Unit, World Health Organization, Genève.
Developments in Biological Standardization
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
Bulletin of the World Health Organization·1995
Availability of vaccines of an assured quality.
Vaccine·1992
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.
Journal of virology·1989
Antibody state to poliovirus in first year university students, 1984.
British medical journal (Clinical research ed.)·1987
International challenges and public policy issues.
Developments in biological standardization·2000
Standardisation and licensing of combination vaccines based on DTP.
Developments in biological standardization·2000
The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics.
Developments in biological standardization·2000
Cytokine and growth factor standardization: the need for research to answer modern issues.
Developments in biological standardization·2000
Alternatives to the use of animals for bacterial toxins and antitoxins.
Developments in biological standardization·2000
Cell substrates: lessons learned and challenges remaining.
Developments in biological standardization·2000
Making the Case for Organ-on-Chip Platforms in Long-Acting Therapeutics Development.
Advanced healthcare materials·2026
Increased Odds of Perioperative Complications Following Lumbar Diskectomy Among Patients With a Colostomy.
Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews·2026